| Date Filed | Type | Description |
| 03/03/2023 |
4
| Huang Dennis Karl (See Remarks) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 2,663 shares
@ $0
Granted 22,000 shares
@ $0
Sold 389 shares
@ $45.65, valued at
$17.8k
Disposed/sold 10,599 shares
@ $45.65, valued at
$483.8k
Granted 39,400 options to buy
@ $45.65, valued at
$1.8M
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2021 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 358 shares
@ $81.14, valued at
$29k
|
|
| 05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 262 shares
@ $88, valued at
$23.1k
|
|
| 06/03/2020 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 262 shares
@ $69.38, valued at
$18.2k
|
|
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2020 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 248 shares
@ $58.57, valued at
$14.5k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,434 shares
@ $0 |
|
| 06/04/2019 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 260 shares
@ $54.93, valued at
$14.3k
|
|
| 05/07/2019 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 649 shares
@ $67.99, valued at
$44.1k
Granted 1,434 shares
@ $0 |
|
| 04/23/2019 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 248 shares
@ $64.43, valued at
$16k
|
|
| 04/17/2019 |
4/A
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 6,000 shares
@ $0
Sold 626 shares
@ $65.52, valued at
$41k
Granted 20,000 options to buy
@ $67.55, valued at
$1.4M
|
|
| 03/04/2019 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 6,000 shares
@ $0
Paid exercise price by delivering 607 shares
@ $67.55, valued at
$41k
Granted 20,000 options to buy
@ $67.55, valued at
$1.4M
|
|
| 06/04/2018 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 260 shares
@ $73.73, valued at
$19.2k
|
|
| 05/08/2018 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 649 shares
@ $54.5, valued at
$35.4k
|
|
| 04/19/2018 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,431 shares
@ $0 |
|
| 03/05/2018 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 4,500 shares
@ $0
Paid exercise price by delivering 205 shares
@ $48.43, valued at
$9.9k
Granted 25,000 options to buy
@ $48.43, valued at
$1.2M
|
|
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/08/2017 |
4
| Huang Dennis Karl (EVP & Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 705 shares
@ $61.08, valued at
$43.1k
|
|
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2016 |
4
| Huang Dennis Karl (SVP and Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 17,800 options to buy
@ $70.57, valued at
$1.3M
|
|
| 05/09/2016 |
4
| Huang Dennis Karl (SVP and Chief Tech Ops Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 705 shares
@ $62.45, valued at
$44k
|
|